Gary Andrew Rhodes expands Screen My Bones to Norway

From boardrooms to city halls, Gary Andrew Rhodes’ visionary bone health initiative is gaining rapid traction in Norway, Denmark, and Germany—reframing aging with proactive, data-driven solutions that serve the economy-driving generation.

While most healthcare systems remain trapped in reactive cycles—treating musculoskeletal issues after a fracture—Rhodes is leading a global shift: one that anticipates, strengthens, and prevents. His mission? To future-proof individuals and economies through earlier, smarter interventions.

Through Screen My Bones™, Rhodes is deploying scalable, mobile, and deeply integrated systems that deliver early detection, safe skeletal loading, and precise referral pathways—without hospitals, radiation, or long delays. It’s healthcare in real time, placed directly in the hands of the people and into the rhythm of everyday life.

At the center of this innovation is Echolight REMS technology—a non-invasive, radiation-free advancement that measures both bone density and bone quality. Combined with Biodensity® and Power Plate®, Screen My Bones doesn’t just screen—it strengthens. This trifecta allows for safe skeletal loading, improved balance, and fall prevention—a true first in post-diagnostic intervention.

But Rhodes hasn’t stopped at technology. He has united a global network of experts in nutrition, hormonal health, biomechanics, sleep science, and musculoskeletal medicine to form a multidisciplinary backbone for real, lasting change.

“Osteoporosis is not inevitable,” Rhodes insists. “It’s avoidable—and even when diagnosed, we now have the tools to slow it, stop it, and in many cases, reverse it.”

One critical insight drives his urgency: osteoporosis often begins before age 40—yet most people don’t get screened until after a fracture. Rhodes is determined to change that by embedding bone screening into corporate wellness, community health, and everyday environments.

“We’ve made bone health synonymous with old age. But what if I told you it can start declining at 30?”

“If we want to strengthen economies, we must first strengthen the people building them.”

Historically, a bone scan meant a DEXA scan—used only when something went wrong. But Echolight REMS, coupled with Rhodes’ model, now makes preventative screening proactive, accessible, and immediate.

Following his standout presentation at Norway’s prestigious SHE Conference, Rhodes and his MSK partners from Performance Health Systems caught the attention of global leaders—from the Lord Mayor of Oslo to Google’s Nordic team. The verdict was clear: Screen My Bones™ is not just a healthcare advancement—it’s a societal infrastructure upgrade.

Rhodes has since been invited back for national-level health innovation talks in Norway, with Denmark and Germany opening parallel dialogues. This expands an already-growing footprint in the UK, USA, and Canada, igniting a transatlantic movement toward proactive musculoskeletal longevity.
Already, governments and innovators are studying the “Rhodes Model”: Screening + Strengthening + Systems Integration—a formula that’s proven to reduce emergency visits, support elderly independence, and boost productivity during prime working years.

“Prevention isn’t passive,” Rhodes states. “It requires real tools, real people, and real systems that make staying strong the default—not the exception.”
As governments, employers, and families seek sustainable paths through rising healthcare burdens, Gary Andrew Rhodes is proving one thing:
The future of aging doesn’t start at 65—it starts at 30.

Join Our Channels